Borongan, Mark Jiggy .

HRN: 29-06-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/27/2026
08/03/2026
IV
270mg
Q6h
URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: